SIGNIFICANCE OF CATHEPSIN-D EXPRESSION IN UTERINE-TUMORS

被引:14
作者
SCAMBIA, G
PANICI, PB
FERRANDINA, G
DISTEFANO, M
ROMANINI, ME
SICA, G
MANCUSO, S
机构
[1] CATHOLIC UNIV, DEPT OBSTET & GYNAECOL, I-00168 ROME, ITALY
[2] CATHOLIC UNIV, DEPT HISTOL, I-00168 ROME, ITALY
关键词
CATHEPSIN-D; PROGNOSTIC FACTORS; CERVICAL CANCER; ENDOMETRIAL CANCER;
D O I
10.1016/0959-8049(95)00123-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cathepsin-D (Cath-D) expression was evaluated by an immunoradiometric assay in 67 primary endometrial carcinomas and 70 cervical cancers. In the endometrial tumours, are inverse correlation was observed between Cath-D levels and stage (P = 0.027) and myometrial invasion (P = 0.046). A significant correlation between Cath-D levels and hormone receptor status was demonstrated (P < 0.05). In cervical cancer, no differences in the distribution of Cath-D levels according to clinicopathological parameters and hormone receptors were observed. However, patients not responding to neoadjuvant chemotherapy had significantly lower Cath-D values than those showing complete or partial response (P = 0.011). As far as prognostic significance is concerned, it appears that Cath-D expression might have a different role in the two uterine neoplasias. While our preliminary data in endometrial cancer suggest that high Cath-D levels may be a favourable prognostic indicator, cervical cancer patients with Cath-D+ tumours had a shorter disease-free survival than those with Cath-D- tumours (P = 0.017).
引用
收藏
页码:1449 / 1454
页数:6
相关论文
共 31 条
[1]   PERICELLULAR MATRIX IN MALIGNANT TRANSFORMATION [J].
ALITALO, K ;
VAHERI, A .
ADVANCES IN CANCER RESEARCH, 1982, 37 :111-158
[2]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN GYNECOLOGICAL MALIGNANCIES [J].
BATTAGLIA, F ;
SCAMBIA, G ;
PANICI, PB ;
BAIOCCHI, G ;
PERRONE, L ;
IACOBELLI, S ;
MANCUSO, S .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1989, 27 (01) :42-44
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   CATHEPSIN D ASSAY IN PRIMARY BREAST-CANCER AND LYMPH-NODES - RELATIONSHIP WITH C-MYC, C-ERB-B-2 AND INT-2 ONCOGENE AMPLIFICATION AND NODE INVASIVENESS [J].
BROUILLET, JP ;
THEILLET, C ;
MAUDELONDE, T ;
DEFRENNE, A ;
SIMONYLAFONTAINE, J ;
SERTOUR, J ;
PUJOL, H ;
JEANTEUR, P ;
ROCHEFORT, H .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) :437-441
[5]   PHOSPHORYLATION, GLYCOSYLATION, AND PROTEOLYTIC ACTIVITY OF THE 52-KD ESTROGEN-INDUCED PROTEIN SECRETED BY MCF7 CELLS [J].
CAPONY, F ;
MORISSET, M ;
BARRETT, AJ ;
CAPONY, JP ;
BROQUET, P ;
VIGNON, F ;
CHAMBON, M ;
LOUISOT, P ;
ROCHEFORT, H .
JOURNAL OF CELL BIOLOGY, 1987, 104 (02) :253-262
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]  
ELANGOVAN S, 1980, J BIOL CHEM, V255, P7474
[8]   CATHEPSIN-D IN PRIMARY SQUAMOUS LARYNGEAL TUMORS - CORRELATION WITH CLINICOPATHOLOGICAL PARAMETERS AND RECEPTOR STATUS [J].
FERRANDINA, G ;
SCAMBIA, G ;
PANICI, PB ;
ALMADORI, G ;
PALUDETTI, G ;
CADONI, G ;
DISTEFANO, M ;
MAURIZI, M ;
MANCUSO, S .
CANCER LETTERS, 1992, 67 (2-3) :133-138
[9]   PROGNOSTIC VALUE OF PS2 AND CATHEPSIN-D IN 710 HUMAN PRIMARY BREAST-TUMORS - MULTIVARIATE-ANALYSIS [J].
FOEKENS, JA ;
VANPUTTEN, WLJ ;
PORTENGEN, H ;
DEKONING, HYWCM ;
THIRION, B ;
ALEXIEVAFIGUSCH, J ;
KLIJN, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :899-908
[10]   RELATIONSHIP BETWEEN CATHEPSIN-D, UROKINASE, AND PLASMINOGEN-ACTIVATOR INHIBITORS IN MALIGNANT VS BENIGN BREAST-TUMORS [J].
FOUCRE, D ;
BOUCHET, C ;
HACENE, K ;
POURREAUSCHNEIDER, N ;
GENTILE, A ;
MARTIN, PM ;
DESPLACES, A ;
OGLOBINE, J .
BRITISH JOURNAL OF CANCER, 1991, 64 (05) :926-932